CN101332316B - 生物型鼻梁植入体 - Google Patents

生物型鼻梁植入体 Download PDF

Info

Publication number
CN101332316B
CN101332316B CN200810029656.0A CN200810029656A CN101332316B CN 101332316 B CN101332316 B CN 101332316B CN 200810029656 A CN200810029656 A CN 200810029656A CN 101332316 B CN101332316 B CN 101332316B
Authority
CN
China
Prior art keywords
biotype
nose bridge
implantation body
handles
epoxide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN200810029656.0A
Other languages
English (en)
Other versions
CN101332316A (zh
Inventor
徐国风
徐斌
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Guanhao Biotech Co ltd
Original Assignee
GUANGDONG SUMMIT LIFE SCIENCES CO Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by GUANGDONG SUMMIT LIFE SCIENCES CO Ltd filed Critical GUANGDONG SUMMIT LIFE SCIENCES CO Ltd
Priority to CN200810029656.0A priority Critical patent/CN101332316B/zh
Priority to US12/284,816 priority patent/US20100023124A1/en
Publication of CN101332316A publication Critical patent/CN101332316A/zh
Priority to PCT/CN2009/000818 priority patent/WO2010009616A1/en
Priority to RU2011102170/15A priority patent/RU2499612C2/ru
Priority to JP2011519006A priority patent/JP2011528586A/ja
Priority to EP09799932.0A priority patent/EP2320966B1/en
Priority to US13/361,563 priority patent/US20120128785A1/en
Application granted granted Critical
Publication of CN101332316B publication Critical patent/CN101332316B/zh
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3641Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the site of application in the body
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/18Internal ear or nose parts, e.g. ear-drums
    • A61F2/186Nose parts
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/32Bones; Osteocytes; Osteoblasts; Tendons; Tenocytes; Teeth; Odontoblasts; Cartilage; Chondrocytes; Synovial membrane
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/02Peptides of undefined number of amino acids; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3604Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the human or animal origin of the biological material, e.g. hair, fascia, fish scales, silk, shellac, pericardium, pleura, renal tissue, amniotic membrane, parenchymal tissue, fetal tissue, muscle tissue, fat tissue, enamel
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3683Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00Materials or treatment for tissue regeneration
    • A61L2430/40Preparation and treatment of biological tissue for implantation, e.g. decellularisation, cross-linking

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Botany (AREA)
  • Immunology (AREA)
  • Otolaryngology (AREA)
  • Vascular Medicine (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Zoology (AREA)
  • Pulmonology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Rheumatology (AREA)
  • Virology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Materials For Medical Uses (AREA)
  • Peptides Or Proteins (AREA)
  • Prostheses (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

本发明公开了一种生物型鼻梁植入体,它是以动物的肌腱或韧带为原料,按如下步骤制成:(1)对动物的肌腱或韧带进行预处理;(2)脱细胞处理;(3)加工成型;(4)环氧交联固定处理;(5)除抗原处理;(6)病毒灭活;(7)诱导活性修饰;(8)灭菌。本发明的生物型鼻梁植入体是纯天然材料制成,它的组成及结构与人体组织相似,生物相容性好,稳定性高,不轻易降解,只有在宿主组织长入时才作被动降解,植入不引起免疫排斥反应,可诱导组织再生,与宿主周围组织长合为一体,并逐渐变为宿主组织,有真实质感,无异物刺激,不会发生移位、蚀穿外露等并发症。动物实验及临床试验效果良好,是新一代天然鼻梁植入体。

Description

生物型鼻梁植入体
技术领域
本发明涉及医用植入器械领域,具体地说,涉及一种鼻梁植入体。
背景技术
隆鼻是美容整容最常见的手术,目前用于隆鼻的鼻梁植入体全是由硅橡胶或膨体聚四氟乙烯制成,这两种材料虽然具有生物惰性,植入后可与人体和平共处。但由于其组成和结构与人体无任何相似,无法与受主组织长合为一体,易发生移位、磨损,蚀穿外露,细心观察质感仍有差异等缺点。
发明内容
本发明的目的是提供一种生物相容性良好,无免疫排异反应,能与受主组织愈合为一体的生物型鼻梁植入体。
为了实现上述目的,本发明采用如下技术方案:
一种生物型鼻梁植入体,它是以动物的肌腱或韧带为原料,按如下步骤制成:
(1)对动物的肌腱或韧带进行预处理;
(2)脱细胞处理;
(3)加工成型;
(4)环氧交联固定处理;
(5)除抗原处理;
(6)病毒灭活;
(7)诱导活性修饰;
(8)灭菌。
在上述步骤中,步骤(1)所述预处理为采用广谱消毒剂浸泡消毒,去除杂质,并修剪成易于成型的坯料。
在上述步骤中,步骤(2)所述的脱细胞处理是用酶将细胞壁酶解或用表面活性剂破坏细胞壁并进行洗脱处理,以脱除其中的细胞,也可以两者兼用。酶解法是用胃蛋白酶或胰蛋白酶或两者的复合酶分解破坏其中的细胞。表面活性剂优选曲拉通X100、吐温-20或OP-10。
在上述步骤中,步骤(3)所述的加工成型是指通过模具及机械加工的方法将坯料加工成尾部为一个弧形薄翼,向头部逐渐收窄为柱体,头部为一曲尺状柱体,弯曲处为一半球形前突,与鼻突对应。
在上述步骤中,步骤(4)所述的环氧交联固定处理是将环氧化物与软骨以及基底骨中的胶原蛋白进行开环交联反应,使其中骨胶原保持稳定,不易变质和被微生物分解。所述环氧化物为
Figure S2008100296560D00021
,R=CnH2n+1或者是
Figure S2008100296560D00022
,n为0~12中的整数。环氧化物浓度为0.1~1mol/L,反应温度在0℃~45℃之间选取,反应时间随所要求的稳定度而定,时间长稳定度高,不易降解,一般在2~96小时之间。
在上述步骤中,步骤(5)所述的除抗原处理是指用除抗原剂封闭引起免疫排异反应的特异基团和改变其引起免疫排异反应的特异构象。封闭特异基团所用的除抗原剂主要是一些易与-NH2,-OH,-SH等基团中的活泼氢起反应的亲核试剂,它们是酸酐、酰氯、酰胺、环氧化物等;改变特异构象的除抗原剂是胍类化合物(如盐酸胍)等强氢键形成剂。
在上述步骤中,步骤(6)的病毒灭活步骤是采用1mol/L氢氧化钠溶液浸泡制品至少60分钟,温度为33~37℃。该步骤主要是为灭活可能存在的朊病毒而设计的,它能使朊病毒失活。
在上述步骤中,步骤(7)所述的诱导活性修饰是将可粘附生长因子及细胞的活性物质引入制品中,使植入后能粘附、富集机体自我修复机制释放并输送到创伤区的生长因子及干细胞,在制品上长时间高效表达,诱导干细胞定向分化为修复组织的母细胞,再分裂增殖,再生出新的组织,最终自体化为自身的鼻梁组织。所用的活性物质是多肽或糖胺聚糖。多肽主要是含16个赖氨酸及精-甘-天冬氨酸的一类多肽,如赖(16)-甘-精-甘-天冬-丝-脯-半胱多肽;糖胺聚糖主要是透明质酸、硫酸软骨素、硫酸皮质素、硫酸角质素、肝素、硫酸乙酰肝素一类粘多糖物质。引入方式可以是偶联、化学吸附、物理吸附和胶原膜包裹等;优选偶联方式,偶联剂可用二酸内酐,二酰二胺,二酰二氯,双环氧化物,碳化二亚胺等双官能团物质。
在上述步骤中,步骤(8)所述的灭菌是用指用中国药典及美国药典规定的25KGy的Co60-γ射线辐照灭菌法。该法能杀灭除朊病毒外的已知病原体。
与现有技术相比,本发明具有如下有益效果:
与目前应用的硅橡胶及膨体聚四氟乙烯的鼻梁植入体相比,本发明的生物型鼻梁植入体的优点在于它是纯天然材料制成,以动物的肌腱/韧带为原料,经炼制和加工成型,再经环氧固定,多方位除抗原技术及组织诱导技术等系列生化技术处理制成。它的组成及结构与人体组织相似,生物相容性好,稳定性高,不轻易降解,只有在宿主组织长入时才作被动降解,植入不引起免疫排斥反应,可诱导组织再生,与宿主周围组织长合为一体,并逐渐变为宿主组织,有真实质感,无异物刺激,不会发生移位,蚀穿外露等并发症。动物实验及临床试验效果良好,是新一代天然鼻梁植入体。
附图说明
图1是生物型鼻梁植入体的结构示意图;
图2是生物型鼻梁植入体的样品照片;
具体实施方式
实施例1
取新鲜健康猪肌腱,放入0.1质量%新洁尔灭清毒液中浸泡60分钟,取出去除杂质,修剪成坯料,取出,洗净,放入胰蛋白酶的Tris盐酸缓冲液中,在室温下酶解10小时,取出,用水冲洗,放入含1μM苯甲基磺酸氟蛋白酶抑制剂的1%OP-10溶液中,浸泡8小时,取出,在搅拌下用水洗涤三次,取出,沥干水份,用专用模具加工成型为图1所示的形态并定型。放入固定反应器中用交联剂进行交联固定,交联剂为含环氧化物的溶液,环氧化物为
Figure S2008100296560D00041
R=(CH3)3C-CH2-,试剂浓度0.1mol/L,在室温下反应100小时。交联反应完成后,取出、洗净,放入除抗原反应装置中,加入乙酸酐,在室温下反应16小时,取出,洗涤,再用盐酸胍溶液反应一次,反应温度10℃,反应时间8小时,取出、洗净。放入诱导活性修饰专用反应器中,加入赖(16)-甘-精-甘-天冬-丝-脯-半胱多肽及己二酰二氯偶联剂,在25℃下,温和反应16小时,取出,充分洗净。用生理盐水保存液双层塑胶袋封装,送辐照灭菌,即得成品。
实施例2
取新鲜健康牛韧带,放入0.1质量%新洁尔灭清毒液中浸泡60分钟,取出去除杂质,修剪成坯料,取出,洗净,放入胰蛋白酶的Tris盐酸缓冲液中,在室温下酶解20小时,取出,用水冲洗,放入含1μM苯甲基磺酸氟蛋白酶抑制剂的1%OP-10溶液中,浸泡8小时,取出,在搅拌下用水洗涤三次,取出,沥干水份,用专用模具加工成型为图1所示形态并定型。放入固定反应器中用交联剂进行交联固定,交联剂为含环氧化物的溶液,环氧化物为
Figure S2008100296560D00051
R=(CH3)3C-CH2-,试剂浓度为0.5mol/L,在室温下反应50小时。交联反应完成后,取出、洗净,放入除抗原反应装置中,加入乙酰氯,在室温下反应10小时。取出,洗涤。再用盐酸胍溶液反应一次,反应温度10℃,反应时间8小时。取出、洗净,放入1mol/L氢氧化钠溶液中在30℃下浸泡处理60分钟,弃去反应液。用稀酸中和残余氢氧化钠,洗净。放入诱导活性修饰专用反应器中,加入赖(16)-甘-精-甘-天冬-丝-脯-半胱多肽及碳化二亚胺偶联剂,在23℃下,温和反应8小时,取出,充分洗净。用生理盐水保存液双层塑胶袋封装,送辐照灭菌,即得成品。

Claims (4)

1.一种生物型鼻梁植入体,其特征在于它是以动物的肌腱或韧带为原料,按如下步骤制成:
(1)对动物的肌腱或韧带进行预处理;
(2)脱细胞处理;
(3)加工成型;
(4)环氧交联固定处理;
(5)除抗原处理;
(6)病毒灭活;
(7)诱导活性修饰;
(8)灭菌;
步骤(2)所述的脱细胞处理是用酶将细胞壁酶解或用表面活性剂破坏细胞壁并进行洗脱处理;
步骤(4)所述的环氧交联固定处理是将环氧化物与组成材料的基本成份胶原蛋白进行开环交联反应,所述环氧化物为R=CnH2n+1或者是
Figure FSB00000866071800012
n为0~12中的整数;
步骤(5)所述的除抗原处理是采用除抗原剂进行处理,所述除抗原剂为羧酸酐、酰氯、酰胺、环氧化物或胍类化合物;
步骤(6)的病毒灭活步骤是采用1mol/L氢氧化钠溶液浸泡制品至少60分钟,温度为33~37℃;
步骤(7)所述的诱导活性修饰是将活性物质引入制品中;所述活性物质为多肽或糖胺聚糖;引入方式为采用偶联剂偶联、化学吸附、物理吸附或胶原膜包裹。
2.根据权利要求1所述的生物型鼻梁植入体,其特征在于所述多肽为赖(16)-甘-精-甘-天冬-丝-脯-半胱构成的多肽;所述糖胺聚糖为透明质酸、硫酸软骨素、硫酸皮质素、硫酸角质素、肝素或硫酸乙酰肝素;所述偶联剂为羧二酸内酐、二酰二胺、二酰二氯、双环氧化物、或碳化二亚胺。
3.根据权利要求1所述的生物型鼻梁植入体,其特征在于步骤(1)所述预处理为采用广谱消毒剂浸泡消毒,去除杂质和修剪。
4.根据权利要求1所述的生物型鼻梁植入体,其特征在于步骤(8)所述的灭菌是用25KGy的Co60-γ射线辐照灭菌。
CN200810029656.0A 2006-07-28 2008-07-22 生物型鼻梁植入体 Active CN101332316B (zh)

Priority Applications (7)

Application Number Priority Date Filing Date Title
CN200810029656.0A CN101332316B (zh) 2008-07-22 2008-07-22 生物型鼻梁植入体
US12/284,816 US20100023124A1 (en) 2008-07-22 2008-09-25 Biological nasal bridge implant and method of manufacturing
PCT/CN2009/000818 WO2010009616A1 (en) 2008-07-22 2009-07-22 Biological nasal bridge implant and method of manufacture
RU2011102170/15A RU2499612C2 (ru) 2008-07-22 2009-07-22 Биологический имплант переносицы и способ его изготовления
JP2011519006A JP2011528586A (ja) 2008-07-22 2009-07-22 鼻筋用生体インプラント及びその製造方法
EP09799932.0A EP2320966B1 (en) 2008-07-22 2009-07-22 Biological nasal bridge implant and method of manufacture
US13/361,563 US20120128785A1 (en) 2006-07-28 2012-01-30 Biological nasal bridge implant and method of manufacture

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN200810029656.0A CN101332316B (zh) 2008-07-22 2008-07-22 生物型鼻梁植入体

Publications (2)

Publication Number Publication Date
CN101332316A CN101332316A (zh) 2008-12-31
CN101332316B true CN101332316B (zh) 2012-12-26

Family

ID=40195364

Family Applications (1)

Application Number Title Priority Date Filing Date
CN200810029656.0A Active CN101332316B (zh) 2006-07-28 2008-07-22 生物型鼻梁植入体

Country Status (6)

Country Link
US (2) US20100023124A1 (zh)
EP (1) EP2320966B1 (zh)
JP (1) JP2011528586A (zh)
CN (1) CN101332316B (zh)
RU (1) RU2499612C2 (zh)
WO (1) WO2010009616A1 (zh)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101332316B (zh) * 2008-07-22 2012-12-26 广东冠昊生物科技股份有限公司 生物型鼻梁植入体
CN101829359B (zh) * 2010-04-16 2013-04-03 中国人民解放军第二军医大学 脱细胞韧带支架和种子细胞复合培养方法
US9597178B2 (en) 2013-06-05 2017-03-21 ShawHan Biomedical Co. Auricular implant
CN104788692A (zh) * 2015-04-30 2015-07-22 上海欣吉特生物科技有限公司 一种灭活胶原材料及其制备方法
CN106510900A (zh) * 2016-12-08 2017-03-22 大连裕辰科技发展有限公司 一种用于鼻部整形填充同种肋软骨的材料及其制备方法
CN106492282A (zh) * 2016-12-08 2017-03-15 大连裕辰科技发展有限公司 一种用于鼻部整形填充同种异体脱钙骨的材料及其制备方法
BE1025061B1 (fr) 2017-03-17 2018-10-17 Cerhum Société Anonyme Implant nasal

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1394653A (zh) * 2002-06-20 2003-02-05 武汉大学 一种隆鼻材料及其制备方法
CN1903144A (zh) * 2005-07-29 2007-01-31 广东冠昊生物科技有限公司 生物型人工韧带及其制备方法

Family Cites Families (67)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3802437A (en) * 1971-08-02 1974-04-09 G Kees Clip for blood vessel
US3974526A (en) * 1973-07-06 1976-08-17 Dardik Irving I Vascular prostheses and process for producing the same
DE2453363B2 (de) * 1974-11-11 1976-08-26 Solco Basel AG, Birsfelden (Schweiz) Verfahren zur herstellung heterologer arterientransplantate
AU516741B2 (en) * 1978-05-23 1981-06-18 Bio Nova Neo Technics Pty. Ltd. Vascular prostheses
US4481009A (en) * 1982-05-13 1984-11-06 American Hospital Supply Corporation Polymer incorporation into implantable biological tissue to inhibit calcification
US5217492A (en) * 1982-09-29 1993-06-08 Bio-Metric Systems, Inc. Biomolecule attachment to hydrophobic surfaces
US4597766A (en) * 1984-10-26 1986-07-01 American Hospital Supply Corporation Implantable bioprosthetic tendons and ligaments
US4765335A (en) * 1987-03-16 1988-08-23 Intermar, Inc. Aneurysm clip
US5735902A (en) * 1987-07-20 1998-04-07 Regen Biologics, Inc. Hand implant device
JP2529112B2 (ja) * 1987-08-31 1996-08-28 株式会社 高研 生体弁
US5078744A (en) * 1987-09-04 1992-01-07 Bio-Products, Inc. Method of using tendon/ligament substitutes composed of long, parallel, non-antigenic tendon/ligament fibers
US4793344A (en) * 1987-11-02 1988-12-27 Recore, Inc. Method for preparing corneal donor tissue for refractive eye surgery
US5067962A (en) * 1989-04-18 1991-11-26 Baxter International Inc. Bioprosthetic ligament
US4994084A (en) * 1989-06-23 1991-02-19 Brennan H George Reconstructive surgery method and implant
FR2649982B1 (fr) * 1989-07-20 1991-09-27 Inst Nat Sante Rech Med Membrane biologique artificielle
EP0491860B1 (en) * 1989-09-15 1997-01-15 Chiron Vision Corporation Synthetic material for supporting the attachment, growth and migration of epithelial cells, prosthetic device for subepithelial implantation and lens treated
US5133754A (en) * 1991-03-21 1992-07-28 Laghi Aldo A Multi hardness silicone implants
US5290217A (en) * 1991-10-10 1994-03-01 Earl K. Sipes Method and apparatus for hernia repair
JP3532565B2 (ja) * 1991-12-31 2004-05-31 ミネソタ マイニング アンド マニュファクチャリング カンパニー 再剥離型低溶融粘度アクリル系感圧接着剤
US5447536A (en) * 1994-02-17 1995-09-05 Biomedical Design, Inc. Method for fixation of biological tissue
US5549666A (en) * 1994-09-02 1996-08-27 Baxter International Inc. Natural tissue valve prostheses having variably complaint leaflets
AU5370396A (en) * 1995-03-24 1996-10-16 Life Resuscitation Technologies, Inc. Vessel and duct salvage device and method
US5711969A (en) * 1995-04-07 1998-01-27 Purdue Research Foundation Large area submucosal tissue graft constructs
US20020095218A1 (en) * 1996-03-12 2002-07-18 Carr Robert M. Tissue repair fabric
DE69629679T3 (de) * 1995-06-07 2011-07-07 Edwards Lifesciences Corp., Calif. Verstärktes gefässimplantat mit einem äusserlich unterstützten band
US5984858A (en) * 1995-06-07 1999-11-16 Crosscart, Inc. Meniscal xenografts
US5902338A (en) * 1995-09-15 1999-05-11 Crosscart, Inc. Anterior cruciate ligament heterograft
US6458889B1 (en) * 1995-12-18 2002-10-01 Cohesion Technologies, Inc. Compositions and systems for forming crosslinked biomaterials and associated methods of preparation and use
US6666892B2 (en) * 1996-08-23 2003-12-23 Cook Biotech Incorporated Multi-formed collagenous biomaterial medical device
ES2213835T3 (es) * 1996-09-16 2004-09-01 Purdue Research Foundation Injerto de tejidos intestinales submucosales para la reparacion de tejidos neurologicos.
US6545042B2 (en) * 1996-11-05 2003-04-08 Gp Medical Acellular biological material chemically treated with genipin
US6117979A (en) * 1997-08-18 2000-09-12 Medtronic, Inc. Process for making a bioprosthetic device and implants produced therefrom
US6482584B1 (en) * 1998-11-13 2002-11-19 Regeneration Technologies, Inc. Cyclic implant perfusion cleaning and passivation process
US6008292A (en) * 1997-12-02 1999-12-28 Baxter International Inc. Method for inhibiting calcification of aldehyde-fixed bioprosthetic materials
DE19809121C1 (de) * 1998-03-04 1999-08-12 Aesculap Ag & Co Kg Gefäßclip
FR2777284B1 (fr) * 1998-04-10 2000-05-26 Hamza Mansour Procede de sterilisation d'un collagene natif en milieu liquide, collagene natif sterile obtenu, compositions le contenant et applications
AU763724B2 (en) * 1998-06-05 2003-07-31 Duke University School Of Medicine Bioengineered vascular graft support prostheses
US6106555A (en) * 1998-12-15 2000-08-22 Av Healing Llc Method for tissue fixation
US6267786B1 (en) * 1999-02-11 2001-07-31 Crosscart, Inc. Proteoglycan-reduced soft tissue xenografts
US6177514B1 (en) * 1999-04-09 2001-01-23 Sulzer Carbomedics Inc. Blocked functional reagants for cross-linking biological tissues
WO2000064371A1 (en) * 1999-04-27 2000-11-02 The Children's Hospital Of Philadelphia Stabilization of implantable bioprosthetic devices
US6312474B1 (en) * 1999-09-15 2001-11-06 Bio-Vascular, Inc. Resorbable implant materials
DE10026306A1 (de) * 2000-05-26 2001-11-29 Tutogen Medical Gmbh Transplantat
US9387094B2 (en) * 2000-07-19 2016-07-12 Warsaw Orthopedic, Inc. Osteoimplant and method of making same
EP1320390A2 (en) * 2000-09-18 2003-06-25 Organogenesis Inc. Bioengineered flat sheet graft prosthesis and its use
US7077851B2 (en) * 2000-10-17 2006-07-18 Aesculap Ag & Co. Kg Aneurysm clip
US6867012B2 (en) * 2000-12-05 2005-03-15 Toyo Boseki Kabushiki Kaisha Determination method of biological component and reagent kit used therefor
US8877233B2 (en) * 2001-06-29 2014-11-04 Cook Biotech Incorporated Porous sponge matrix medical devices and methods
WO2003080143A1 (fr) * 2002-03-25 2003-10-02 Kaken Pharmaceutical Co., Ltd. Materiau de base de reconstruction de tissu ou d'organe contenant une matrice tissulaire sans cellule et un facteur de croissance cellulaire
US7273896B2 (en) * 2003-04-10 2007-09-25 Angiotech Pharmaceuticals (Us), Inc. Compositions and methods of using a transient colorant
RU2249462C1 (ru) * 2003-08-21 2005-04-10 Севастьянов Виктор Иванович Универсальный гетерогенный коллагеновый матрикс для имплантации и способ его получения
EP1684816B1 (en) * 2003-10-28 2009-05-06 Medtronic, Inc. Methods of preparing crosslinked materials and bioprosthetic devices
US7955788B2 (en) * 2003-10-30 2011-06-07 Medtronic, Inc. Bioprosthetic tissue preparation with synthetic hydrogels
US20050208095A1 (en) * 2003-11-20 2005-09-22 Angiotech International Ag Polymer compositions and methods for their use
US7615375B2 (en) * 2003-12-18 2009-11-10 Xerox Corporation Osmotic reaction cell for monitoring biological and non-biological reactions
US7648676B2 (en) * 2004-04-20 2010-01-19 Rti Biologics, Inc. Process and apparatus for treating implants comprising soft tissue
US20050244460A1 (en) * 2004-04-29 2005-11-03 Ivan Alferiev Biodegradable crosslinking strategies using triglycidyl amine (TGA)
CN101128225B (zh) * 2004-12-24 2011-06-15 塞尔克斯塞尔有限公司 可植入生物材料和制造它的方法
CN1986007B (zh) * 2005-12-20 2011-09-14 广东冠昊生物科技股份有限公司 生物型外科补片
CN1986006A (zh) * 2005-12-20 2007-06-27 广州知光生物科技有限公司 生物型神经导管
CN1986001B (zh) * 2005-12-20 2011-09-14 广东冠昊生物科技股份有限公司 生物护创膜
CN101332316B (zh) * 2008-07-22 2012-12-26 广东冠昊生物科技股份有限公司 生物型鼻梁植入体
US20080171906A1 (en) * 2007-01-16 2008-07-17 Everaerts Frank J L Tissue performance via hydrolysis and cross-linking
US20080195229A1 (en) * 2007-02-09 2008-08-14 Quijano Rodolfo C Decellularized pericardial tissue
CN101172165A (zh) * 2007-11-16 2008-05-07 广东冠昊生物科技有限公司 生物型骨修复材料
CN201182778Y (zh) * 2007-11-16 2009-01-21 广州知光生物科技有限公司 生物型骨修复材料
CN201271394Y (zh) * 2008-07-22 2009-07-15 广州知光生物科技有限公司 生物型鼻梁植入体

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1394653A (zh) * 2002-06-20 2003-02-05 武汉大学 一种隆鼻材料及其制备方法
CN1903144A (zh) * 2005-07-29 2007-01-31 广东冠昊生物科技有限公司 生物型人工韧带及其制备方法

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
田晋洪 等.隆鼻术中各种充填材料的比较.《中国美容医学》.2006,第15卷(第5期),第605-607页. *

Also Published As

Publication number Publication date
EP2320966A4 (en) 2012-09-26
CN101332316A (zh) 2008-12-31
US20100023124A1 (en) 2010-01-28
EP2320966B1 (en) 2013-09-11
RU2011102170A (ru) 2012-07-27
US20120128785A1 (en) 2012-05-24
RU2499612C2 (ru) 2013-11-27
WO2010009616A1 (en) 2010-01-28
EP2320966A1 (en) 2011-05-18
JP2011528586A (ja) 2011-11-24

Similar Documents

Publication Publication Date Title
CN101332316B (zh) 生物型鼻梁植入体
CN101332314B (zh) 生物型关节软骨修补件
CN101433735B (zh) 一种sis组织修复材料的制备方法
ES2720137T3 (es) Método para el tratamiento enzimático de productos tisular
CA2173547C (en) A raw membranous material for medical materials and manufacturing methods thereof
US20090162452A1 (en) EB Matrix Production From Animal Tissue And Its Use For Tissue Repair
CN101427947B (zh) 一种多功能女性盆腔生物补片
CN101371932A (zh) 生物型人工颌骨
JP2006230749A (ja) 軟骨組織に補綴材を固定するための材料
CN101773687A (zh) 一种复合软组织补片的制备方法
CN109364298A (zh) 一种脱细胞真皮基质材料的制备方法
CN108653814A (zh) 一种脱细胞软骨基质材料的制备方法
US20120022233A1 (en) Collagen implant
CN114796615B (zh) 一种软骨脱细胞基质及其制备方法
CN101396292B (zh) 一体化尿道吊带
CN100366303C (zh) 肌腱、韧带防粘连生物膜的制备及应用
CN201227335Y (zh) 生物型关节软骨修补件
CN101411648A (zh) 一种生物型迷你尿道吊带
CN105169493B (zh) 一种人工异种皮肤的制备方法
CN113750293A (zh) 骨修复材料的制备方法
CN201356676Y (zh) 一种生物型迷你尿道吊带
CN110960731A (zh) 一种医用外科生物补片的制备方法
CN1796544A (zh) 细胞胶原脊髓组织的制备及应用
CN1796545A (zh) 干细胞与胶原促生脑组织的制备及应用

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
ASS Succession or assignment of patent right

Owner name: GUANGDONG GUAN HAO BIOLOGICAL SCIENCE + TECHNOLOGY

Free format text: FORMER OWNER: CANTON ZHIGUANG BIOTECHNOLOGY CO., LTD.

Effective date: 20090612

C41 Transfer of patent application or patent right or utility model
TA01 Transfer of patent application right

Effective date of registration: 20090612

Address after: Room 408, D international business incubator, Guangzhou Science City, Guangdong City, Guangzhou Province, 510663, China:

Applicant after: Grandhope Biotech Co.,Ltd.

Address before: Room 2204, east ring building, 474 Ring Road, Guangdong, Guangzhou Province, China: 510075

Applicant before: Guangzhou Zhiguang Biotechnology Co.,Ltd.

C14 Grant of patent or utility model
GR01 Patent grant
C41 Transfer of patent application or patent right or utility model
C56 Change in the name or address of the patentee
CP03 Change of name, title or address

Address after: 510530 Guangdong city of Guangzhou province Luogang District jade Yan Road No. 12

Patentee after: GUANHAO BIOTECH CO.,LTD.

Address before: 510663 Room 408, D international business incubator, Guangzhou Science City, Guangzhou, Guangdong, Guangzhou

Patentee before: Grandhope Biotech Co.,Ltd.

TR01 Transfer of patent right

Effective date of registration: 20160330

Address after: 510530 Guangdong province high tech Industrial Development Zone of Guangzhou Science City skim Springs Road No. 3, Guangzhou international business incubator District D Room 401

Patentee after: GUANGZHOU MEIHAO BIOTECHNOLOGY CO.,LTD.

Address before: 510530 Guangdong city of Guangzhou province Luogang District jade Yan Road No. 12

Patentee before: GUANHAO BIOTECH CO.,LTD.

TR01 Transfer of patent right

Effective date of registration: 20200430

Address after: 510000 Yuyan Road, Whampoa District, Guangzhou, Guangdong Province, No. 12

Patentee after: GUANHAO BIOTECH Co.,Ltd.

Address before: Room 401, Zone D, Guangzhou International Business Incubator, No. 3, juaquan Road, Science City, Guangzhou high tech Industrial Development Zone

Patentee before: GUANGZHOU MEIHAO BIOTECHNOLOGY Co.,Ltd.

TR01 Transfer of patent right